BPC-157
Synthetic pentadecapeptide researched for cytoprotective and tissue-repair signals; not FDA-approved for human use.
Open →TB-500
Fragment derived from thymosin beta-4; explored for tissue repair/angiogenesis in preclinical models.
Open →GHK-Cu
Naturally occurring tripeptide complexed with copper; studied for skin remodeling and wound-healing signals.
Open →CJC-1295
GHRH analog studied for pulsatile GH/IGF-1 modulation; variants with/without DAC.
Open →MOD GRF (1-29)
Short-acting GHRH analog; paired with GHRPs in research contexts.
Open →Ipamorelin
Selective ghrelin receptor agonist (GHRP class) investigated for GH pulse support.
Open →Sermorelin
GHRH analog formerly used diagnostically; studied for GH deficiency contexts.
Open →Tesamorelin
GHRH analog approved for HIV-associated lipodystrophy reduction of excess visceral adipose tissue.
Open →Hexarelin
Potent GHRP agonist; investigated for GH release and cardioprotective research.
Open →GHRP-2
Ghrelin receptor agonist studied for GH pulse; appetite effects common in research reports.
Open →GHRP-6
Ghrelin receptor agonist studied for GH pulse; known orexigenic effects in reports.
Open →Follistatin 344
Binding protein fragment that antagonizes activin/myostatin pathways in models; limited clinical data.
Open →AOD-9604
Fragment of human GH (176-191) researched for lipolysis; mixed regulatory status by country.
Open →Melanotan II
MC1/MC4 receptor agonist; studied for melanogenesis and libido; adverse effects reported.
Open →PT-141 (Bremelanotide)
MC4R agonist; FDA-approved nasal form for hypoactive sexual desire disorder in premenopausal women.
Open →Selank
Heptapeptide with reported anxiolytic/neuromodulatory signals; Russian literature primary.
Open →Semax
ACTH(4-10) analog reported for nootropic/neurotrophic effects in Russian sources.
Open →N-Acetyl Semax Amidate (NAS)
Acetylated/amidated Semax analog discussed for neurotrophic signaling; limited peer-reviewed data.
Open →Thymosin Alpha 1 (TA1)
Synthetic 28-aa peptide (thymalfasin) with immunomodulatory properties; used in some countries.
Open →LL-37
Human cathelicidin antimicrobial peptide; studied for innate immunity and wound models.
Open →DSIP
Endogenous neuropeptide reported to influence sleep regulation in early literature; mixed evidence.
Open →MOTS-c
Mitochondrial-derived peptide studied for metabolic signaling and exercise-related benefits (preclinical).
Open →5-Amino-1MQ
Small-molecule-like peptide derivative targeting NNMT; researched for adiposity/metabolic effects.
Open →KPV
Tripeptide fragment of alpha-MSH studied for anti-inflammatory/skin barrier signaling.
Open →P21
Peptide associated with neurotrophic/cognitive research; limited peer-reviewed human data.
Open →Dihexa
Angiotensin IV derivative investigated for HGF/c-Met pathway interactions and cognitive effects in models.
Open →Kisspeptin-10
Decapeptide regulating GnRH secretion; studied for reproductive axis diagnostics.
Open →Gonadorelin
Synthetic GnRH used diagnostically; stimulates LH/FSH secretion.
Open →Humanin
Mitochondria-derived peptide studied for cytoprotective/oxidative stress pathways.
Open →SS-31 (Elamipretide)
Mitochondria-targeting tetrapeptide investigated clinically for cardiomyopathy/mitochondrial disease.
Open →Epitalon
Synthetic tetrapeptide proposed to influence telomere/telomerase in limited literature; controversial.
Open →Thymalin
Thymic extract-derived peptide complex; historical Russian literature for immune modulation.
Open →PEG-MGF
IGF-1 splice variant analog; studied for localized muscle signaling in models.
Open →IGF-1 LR3
Long R3 IGF-1 analog with reduced binding to IGF-binding proteins; research-only contexts.
Open →Oxytocin
Nonapeptide hormone; intranasal forms studied clinically for social bonding and lactation support.
Open →Desmopressin (DDAVP)
Synthetic vasopressin analog used for diabetes insipidus and nocturia; approved drug.
Open →Semaglutide
GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management.
Open →Tirzepatide
Dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and obesity treatment.
Open →Liraglutide
GLP-1 receptor agonist approved for type 2 diabetes and weight management.
Open →Exenatide
GLP-1 receptor agonist approved for type 2 diabetes management.
Open →Thymopentin (TP5)
Pentapeptide fragment of thymopoietin investigated/used for immunomodulation in some regions.
Open →Peptide T (DAPTA)
Peptide investigated historically for HIV-related indications; limited modern clinical use.
Open →PNC-27
Designed p53-derived peptide reported to form pores in cancer cell membranes; highly experimental/controversial.
Open →PNC-28
Analog of PNC-27 with anticancer claims in early-stage literature; highly experimental/controversial.
Open →Vasoactive Intestinal Peptide (VIP)
Endogenous peptide with vasodilatory/bronchodilatory actions; synthetic forms studied clinically.
Open →PACAP
Neuropeptide with broad neuromodulatory effects; clinical interest in migraine/neurology.
Open →B7-33
Single-chain relaxin analog investigated for anti-fibrotic/cardiovascular effects in preclinical studies.
Open →FOXO4-DRI
Senolytic candidate peptide studied for targeting p53-FOXO4 interaction in models.
Open →Acetyl Hexapeptide-8
Cosmetic peptide targeting expression lines; topical cosmeceutical evidence base.
Open →Palmitoyl Pentapeptide-4
Topical cosmetic peptide studied for dermal matrix signaling and wrinkle appearance.
Open →